Header Logo

Connection

Michael Gottlieb to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Michael Gottlieb has written about Dose-Response Relationship, Drug.
Michael Gottlieb
Connection Strength
0.261
Dose-Response Relationship, Drug
  1. Idarucizumab for the Reversal of Dabigatran. Ann Emerg Med. 2017 May; 69(5):554-558.
    View in: PubMed
    Score: 0.132
  2. Comparison of naproxen with cyclobenzaprine, oxycodone-acetaminophen, and placebo for the treatment of acute low back pain. CJEM. 2016 Nov; 18(6):491-494.
    View in: PubMed
    Score: 0.129
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.